Post a comment
Comments are moderated, and will not appear until the author has approved them.
Your Information
(Name and email address are required. Email address will not be displayed with the comment.)
As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.
Having trouble reading this image? View an alternate.
Comments are moderated, and will not appear until the author has approved them.
Your Information
(Name and email address are required. Email address will not be displayed with the comment.)
Just - WOW! Well done, JB.
I ordered mine in June and was notified yesterday that it won't be posted until 19th October. I'm disappointed, of course, but really pleased that it means they must have sold all the first batch of copies.
Posted by: Susan Welch | September 21, 2018 at 05:03 AM
Even the BMJ is saying there is smthg amiss with our lamestream lines of communication NOW :
https://www.bmj.com/content/362/bmj.k3948
Pandemrix vaccine: why was the public not told of early warning signs?
In documents obtained through the pretrial discovery process (see supplementary data on bmj.com), prosecutors suing the Irish Minister of Health, Health Service Executive, Health Products Regulatory Authority, and GSK have found a string of GSK postmarketing safety reports that show a striking difference in the number and frequency of adverse events reported for three GSK pandemic vaccines approved and used across the world: Pandemrix, Arepanrix, a similar H1N1 vaccine that also contained AS03 adjuvant, and an H1N1 vaccine without adjuvant (no brand name is given).
The BMJ learnt of the reports from my colleague Tom Jefferson, a medically trained epidemiologist who was hired as an expert witness by the solicitors representing Aoife Bennett, an Irish woman who developed narcolepsy after vaccination with Pandemrix in 2009. Jefferson took on the case in 2015, and last year the lawyers received a copy of the GSK safety reports that had been emailed within the company and to at least one regulator (Ireland). Adverse event tables embedded in nine reports spanning the four months between December 2009 and March 2010 offer a glimpse into the vaccines’ safety profiles.
“When I saw those tables, I just fell off the chair. A consumer can figure out what’s going on here,” Jefferson told me
Posted by: Hans Litten | September 21, 2018 at 04:42 AM